OPQ’s 2022 Report Shows the Global Task of Ensuring Quality
FDA Law Blog
JULY 18, 2023
The report reiterated a commitment to maintain the supply chain and provides more context about how OPQ—and FDA, more generally—are approaching quality and enforcement as we continue to hurtle past the COVID-19 public health emergency (PHE). That leaves 60% that manufacture at least one application product. and South Korea.
Let's personalize your content